一次性经食管超声心动图探头对休克危重患者进行持续血流动力学监测:一项随机对照临床试验
该多中心随机对照试验纳入550例循环休克患者,按是否使用持续经食管超声心动图(hTEE)及评估频率(至少每4小时 vs 每8小时)分为四组。主要终点为血流动力学不稳定缓解时间,意向性治疗分析(ITT)显示6天内hTEE组与常规治疗组无差异(校正SHR 1.20,95%CI 0.98-1.46,P=0.067)。在72小时hTEE监测期间,hTEE组缓解时间较短(SHR 1.26,95%CI 1.02-1.55,P=0.034),但评估频率无影响,且器官支持时间、ICU及住院时间、28天死亡率均无差异。结论认为hTEE监测或评估频率不影响6天内血流动力学不稳定缓解或死亡率。
要点
- 在550例循环休克患者中,加用hTEE监测未显著缩短6天内血流动力学不稳定缓解时间(校正SHR 1.20,95%CI 0.98-1.46,P=0.067)。
- 在72小时hTEE监测期间,hTEE组血流动力学不稳定缓解时间较短(SHR 1.26,95%CI 1.02-1.55,P=0.034)。
- 评估频率(至少每4小时 vs 每8小时)对血流动力学不稳定缓解时间无影响。
- hTEE组与常规治疗组在器官支持持续时间、ICU及住院时间、28天死亡率方面均无差异。
适用人群与场景
- 纳入550例循环休克危重患者,随机分组后271例hTEE组和274例常规治疗组纳入ITT分析。
处置流程与药物剂量
- hTEE组在常规治疗基础上加用持续经食管超声心动图监测,评估频率至少每4小时或每8小时;常规治疗组未使用hTEE。
研究设计与关键结果
- 研究为随机对照临床试验,纳入550例循环休克患者,按hTEE(使用 vs 不使用)和评估频率(至少每4小时 vs 每8小时)分为四组。
- 主要终点6天内血流动力学不稳定缓解时间:hTEE组 vs 常规治疗组校正SHR 1.20(95%CI 0.98-1.46,P=0.067),无显著差异。
- 72小时hTEE监测期间血流动力学不稳定缓解时间:hTEE组 vs 常规治疗组SHR 1.26(95%CI 1.02-1.55,P=0.034),hTEE组较短。
- 评估频率对血流动力学不稳定缓解时间无影响。
- 低灌注临床体征缓解时间、器官支持持续时间、ICU及住院时间、ICU及住院死亡率、28天死亡率在组间均无差异。
证据类型、等级与局限
- 证据类型:随机对照临床试验(RCT),注册号NCT02048566。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在休克危重患者中,加用hTEE监测或调整血流动力学评估频率未改变6天内血流动力学不稳定缓解或死亡率,作者结论认为hTEE监测或评估频率不影响这些结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Mortality in circulatory shock is high. Enhanced resolution of shock may improve outcomes. We aim to determine whether adding hemodynamic monitoring with continual transesophageal echocardiography (hTEE) to usual care accelerates resolution of hemodynamic instability.
METHODS: 550 patients with circulatory shock were randomly assigned to four groups stratified using hTEE (hTEE vs usual care) and assessment frequency (minimum every 4 h vs 8 h). Primary outcome was time to resolution of hemodynamic instability, analyzed as intention-to-treat (ITT) analysis at day 6 and in a predefined secondary analysis at days 3 and 28.
RESULTS: Of 550 randomized patients, 271 with hTEE and 274 patients with usual care were eligible and included in the ITT analysis. Time to resolution of hemodynamic instability did not differ within the first 6 days [hTEE vs usual care adjusted sub-hazard ratio (SHR) 1.20, 95% confidence interval (CI) 0.98-1.46, p = 0.067]. Time to resolution of hemodynamic instability during the 72 h of hTEE monitoring was shorter in patients with TEE (hTEE vs usual care SHR 1.26, 95% CI 1.02-1.55, p = 0.034). Assessment frequency had no influence. Time to resolution of clinical signs of hypoperfusion, duration of organ support, length of stay and mortality in the intensive care unit and hospital, and mortality at 28 days did not differ between groups.
CONCLUSIONS: In critically ill patients with shock, hTEE monitoring or hemodynamic assessment frequency did not influence resolution of hemodynamic instability or mortality within the first 6 days.
TRIAL REGISTRATION AND STATISTICAL ANALYSIS PLAN: ClinicalTrials.gov Identifier: NCT02048566.
参考来源
- Merz TM, Cioccari L, Frey PM, et al. Continual hemodynamic monitoring with a single-use transesophageal echocardiography probe in critically ill patients with shock: a randomized controlled clinical trial. Intensive Care Med. 2019. PMID: 31273416. doi:10.1007/s00134-019-05670-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。